Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 14, 2015; 21(22): 6952-6964
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6952
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6952
Table 5 Univariate Kaplan Meier and Log-rank analysis of serologic and clinical factor associated with complicated disease course in B1 Crohn’s disease patients (n = 143)
Variable | Internal penetrating and/or stricturing complication | Perianal penetrating complication | CD-related abdominal surgery | |||
HR (95%CI) | PLogRank-value | HR (95%CI) | PLogRank-value | HR (95%CI) | PLogRank-value | |
Gender - male | 1.10 (0.47-2.55) | 0.83 | 2.69 (0.80-9.03) | 0.11 | 0.91 (0.33-2.55) | 0.86 |
Smoking | 3.72 (1.23-11.21)1 | 0.021 | 1.61 (0.36-7.19) | 0.53 | 1.64 (0.45-5.97) | 0.45 |
Location (colon only) | 0.41 (0.17-0.96)1 | 0.041 | 1.00 (0.29-3.43) | 0.99 | 0.61 (0.22-1.74) | 0.36 |
Frequent relapse | 1.10 (0.39-3.07) | 0.85 | 7.29 (1.72-30.99)1 | 0.0071 | 1.64 (0.44-6.10) | 0.46 |
APLA at all | 1.36 (0.59-3.16) | 0.47 | 1.30 (0.40-4.27) | 0.66 | 1.37 (0.49-3.80) | 0.55 |
Anti-β2-GPI at all | 0.56 (0.13-2.32) | 0.42 | 0.99 (0.13-7.70) | 0.99 | 0.33 (0.06-1.81) | 0.20 |
ACA at all | 0.41 (0.13-1.26) | 0.12 | 1.12 (0.23-5.49) | 0.89 | 0.30 (0.07-1.27) | 0.10 |
Anti-PS/PT at all | 1.07 (0.39-2.97) | 0.89 | 1.74 (0.38-8.03) | 0.48 | 1.11 (0.29-4.18) | 0.88 |
- Citation: Sipeki N, Davida L, Palyu E, Altorjay I, Harsfalvi J, Antal Szalmas P, Szabo Z, Veres G, Shums Z, Norman GL, Lakatos PL, Papp M. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn’s disease. World J Gastroenterol 2015; 21(22): 6952-6964
- URL: https://www.wjgnet.com/1007-9327/full/v21/i22/6952.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i22.6952